Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo

Ipriflavone, a synthetic isoflavone that inhibits osteoclastic bone resorption, has been used clinically for the treatment of osteoporosis. However, the anticancer activity of Ipriflavone and its molecular mechanisms in the context of esophageal squamous cell carcinoma (ESCC) have not been investiga...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Shi, Xiaodan, Zhang, Yuanyuan, Xie, Xiaomeng, Pang, Mengjun, Laster, Kyle, Li, Jian, Ma, Xinli, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8222593/
https://ncbi.nlm.nih.gov/pubmed/34178634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.648809
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi